Search

Two studies on multiple myeloma provide new information about diagnosing and treating this blood cancer.

… Monday, December 9, 2019 Summary One study looked at a new drug combination for this blood cancer; the other focused on genetic markers linked to how the disease progresses. Multiple myeloma is a cancer that arises from the type of white blood cells called plasma cells. When normal plasma cells in the

Sloan Kettering Institute investigators have found that a subpopulation of cells within a type of sarcoma called malignant peripheral nerve sheath tumor appear to be similar to a type of neural stem cells.

… Monday, June 14, 2021 Neurofibromatosis type 1 (NF1) is the most common hereditary disease of the nervous system. Overall, it is a rare condition that affects about one in 3,000 people in the United States and worldwide. It is characterized by tumors that grow along the peripheral nerves (the nerves

Patients with secondary rectal cancer after radiotherapy for prostate cancer have shorter survival compared with matched treatment-naïve patients. However, a new study by investigators at MSK has found distinct differences in patient characteristics, available treatment options, and tumor biologic characteristics that may explain the gap.

… Tuesday, April 29, 2025 Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients,  (1) but factors explaining this gap have been unclear. Now, a new study by investigators at Memorial Sloan Kettering Cancer

Learn about Anna-Katerina “Kat” Hadjantonakis, who is Chair of the Sloan Kettering Institute’s Developmental Biology Program.

… Monday, December 30, 2019 Earlier this year, Anna-Katerina “Kat” Hadjantonakis was named Chair of the Sloan Kettering Institute ’s Developmental Biology Program. She succeeded Kathryn Anderson , who had led the program since it launched in 2003. We spoke with Dr. Hadjantonakis about the field of developmental

Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery.

… Monday, February 1, 2010 Summary Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery. Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery. Dr. Singer is a surgical oncologist and leader of Memorial

There are more than 100 subtypes of brain tumors, making them a challenge to accurately diagnose. Now researchers have figured out a way to reliably distinguish them.

… Wednesday, March 14, 2018 Summary Proper diagnosis and classification is vital for brain tumors , but until now it hasn’t been easy. This week an international team of investigators is reporting a new way to distinguish among the 100-plus different subtypes of the disease. There are more than 100 subtypes

Learn why Bobby Logan chose active surveillance for his prostate cancer, and how he was successfully treated after his tumor changed.

… Friday, September 24, 2021 Urologist Behfar Ehdaie believes that active surveillance is a viable option for many patients with prostate cancer . He feels so strongly about this idea that several years ago, he sought out negotiation experts from Harvard Business School and asked to learn techniques he

Researchers at Memorial Sloan Kettering (MSK) reported results, which were highlighted at the American Society of Clinical Oncology (ASCO) press cast, that eight weeks of acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia in cancer survivors. While both acupuncture and CBT-I resulted in clinically meaningful and durable effects among this group, CBT-I was more effective, especially among people with mild insomnia symptoms.

… Wednesday, May 16, 2018 Researchers at Memorial Sloan Kettering (MSK) reported results, which were highlighted at the American Society of Clinical Oncology (ASCO) press cast, that eight weeks of acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia in cancer

New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75.

… Monday, October 6, 2008 New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients who began screenings at age 50 and have had consistently

When an immune cell faces a foe, it has more than chemical weapons at its disposal.

… Thursday, May 23, 2019 Summary Scientists at the Sloan Kettering Institute are exploring how physical forces influence cell behavior — in particular, how immune cells use these forces to enhance their killing power. A few years ago, immunologist Morgan Huse made a startling discovery that would set his